| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-13 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-13 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-11 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-11 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.28 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.28 | 0.4 |